Did we IMPROVE-IT: Thoughts on LDL targeting post-trial?

Expert Review of Cardiovascular Therapy

Volumn 13, Issue 5, 2015, Pages 465-466

  Packard, Chris ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EZETIMIBE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN; HYPOCHOLESTEROLEMIC AGENT;

ACUTE CORONARY SYNDROME; ATHEROSCLEROSIS; DRUG EFFICACY; DRUG SAFETY; HUMAN; HYPERCHOLESTEROLEMIA; NOTE; PRACTICE GUIDELINE; CARDIOVASCULAR DISEASES; CLINICAL TRIAL (TOPIC); DRUG COMBINATION; DRUG EFFECTS; INTERVIEW;

ACUTE CORONARY SYNDROME; ANTICHOLESTEREMIC AGENTS; CARDIOVASCULAR DISEASES; CHOLESTEROL, LDL; CLINICAL TRIALS AS TOPIC; DRUG THERAPY, COMBINATION; EZETIMIBE; HUMANS; SIMVASTATIN;

EID: 84928623608     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/14779072.2015.1034978     Document Type: Note

References (0)